Gene: NUDCD1
Official Full Name: NudC domain containing 1provided by HGNC
Gene Summary: Predicted to be involved in immune system process. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24409 | NUDCD1 Knockout cell line (HeLa) | Human | NUDCD1 | 1:3~1:6 | Negative | Online Inquiry |
KO24410 | NUDCD1 Knockout cell line (HCT 116) | Human | NUDCD1 | 1:2~1:4 | Negative | Online Inquiry |
KO24411 | NUDCD1 Knockout cell line (HEK293) | Human | NUDCD1 | 1:3~1:6 | Negative | Online Inquiry |
KO24412 | NUDCD1 Knockout cell line (A549) | Human | NUDCD1 | 1:3~1:4 | Negative | Online Inquiry |
NUDCD1 Gene Knockout Cell Lines are specialized cell lines engineered to have a targeted disruption of the NUDCD1 gene, which encodes a protein implicated in cellular processes such as DNA repair, chromatin remodeling, and the regulation of the cell cycle. These knockout cell lines offer researchers a powerful tool to study the physiological and pathological roles of the NUDCD1 gene, enabling deeper insights into its contribution to various cellular functions and diseases, including cancer and genetic disorders.
The key mechanism of action involves the use of CRISPR/Cas9 or similar gene-editing technologies to create precise knockouts. This allows for the evaluation of phenotypic changes associated with the absence of NUDCD1, such as alterations in cell proliferation, apoptosis, and DNA damage responses. Researchers can observe the cellular pathways affected by NUDCD1 disruption, thus facilitating the identification of potential therapeutic targets and biomarkers.
The scientific importance of NUDCD1 Gene Knockout Cell Lines extends to both basic research and clinical applications. They provide an invaluable platform for drug discovery, particularly in oncology, where understanding gene function can lead to the development of targeted therapies. Moreover, these cell lines support academic and biopharmaceutical research, fostering collaborations that aim to translate experimental findings into clinical advancements.
One of the distinctive advantages of our NUDCD1 knockout models is their rigorously validated genetic modifications, which minimize off-target effects and enhance reproducibility. Compared to other methods, such as chemical or viral approaches, our knockout lines provide a more straightforward and effective means of studying gene function without the confounding variables introduced by other gene manipulation techniques.
For researchers and clinicians looking to unravel the complexities of cellular mechanisms or develop innovative therapies, the NUDCD1 Gene Knockout Cell Lines represent a valuable asset. Our company, dedicated to advancing biological research, leverages cutting-edge technology and expertise in genetic engineering to offer high-quality, reliable products that support the scientific community in their pursuit of knowledge and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.